Welcome to LookChem.com Sign In|Join Free
  • or
4-(3-methyl-phenyl-amino)-1-(phenylmethyl)-4-piperidine-carboxamide is a complex organic compound with the molecular formula C23H26N2O. It is a derivative of piperidine, a heterocyclic amine, and features a phenylmethyl group (benzyl) and a 3-methylphenylamine group attached to the piperidine ring. 4-(3-methyl-phenyl-amino)-1-(phenylmethyl)-4-piperidine-carboxamide is known for its potential applications in the pharmaceutical industry, particularly as a precursor in the synthesis of certain drugs. Its structure includes a carboxamide group, which is an amide of a carboxylic acid, and it is characterized by its ability to form hydrogen bonds, which can influence its solubility and reactivity. The compound's specific properties and uses are determined by its unique arrangement of functional groups and its molecular structure.

1045-50-7

Post Buying Request

1045-50-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1045-50-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1045-50-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,4 and 5 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1045-50:
(6*1)+(5*0)+(4*4)+(3*5)+(2*5)+(1*0)=47
47 % 10 = 7
So 1045-50-7 is a valid CAS Registry Number.

1045-50-7Relevant academic research and scientific papers

Inhibitors of prenyl-protein transferase

-

, (2008/06/13)

The present invention is directed to conformationally constrained compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.

INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

-

, (2008/06/13)

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1045-50-7